[
  {
    "ts": null,
    "headline": "Zoetis Inc. (ZTS) Q3 2025 Earnings Call Transcript",
    "summary": "Zoetis Inc. (ZTS) Q3 2025 Earnings Call November 4, 2025 8:30 AM ESTCompany ParticipantsSteven Frank - Vice President of Investor RelationsKristin Peck -...",
    "url": "https://finnhub.io/api/news?id=fae29be01811828a2e21de423be7fee66a736d635fe24cbf940f0480bbc32006",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762272989,
      "headline": "Zoetis Inc. (ZTS) Q3 2025 Earnings Call Transcript",
      "id": 137326091,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "ZTS",
      "source": "SeekingAlpha",
      "summary": "Zoetis Inc. (ZTS) Q3 2025 Earnings Call November 4, 2025 8:30 AM ESTCompany ParticipantsSteven Frank - Vice President of Investor RelationsKristin Peck -...",
      "url": "https://finnhub.io/api/news?id=fae29be01811828a2e21de423be7fee66a736d635fe24cbf940f0480bbc32006"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis Crumbles On Slashed 2025 Outlook As Growth Fears Mount",
    "summary": "Zoetis stock took a hit Tuesday after the animal health outlet slashed its 2025 sales outlook on the back of \"broader macro trends.\"",
    "url": "https://finnhub.io/api/news?id=4b5de136b8449cd80adec355ab8f4f51eea7a6f6add217e9c765771440fcf764",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762266467,
      "headline": "Zoetis Crumbles On Slashed 2025 Outlook As Growth Fears Mount",
      "id": 137312647,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "Zoetis stock took a hit Tuesday after the animal health outlet slashed its 2025 sales outlook on the back of \"broader macro trends.\"",
      "url": "https://finnhub.io/api/news?id=4b5de136b8449cd80adec355ab8f4f51eea7a6f6add217e9c765771440fcf764"
    }
  },
  {
    "ts": null,
    "headline": "This Animal Health Stock Tanks on Earnings. Pig and Chicken Medication Revenue Slumps.",
    "summary": "Shares of  Zoetis  slumped Tuesday after the animal healthcare company reported weaker-than-expected quarterly revenue and slashed its full-year outlook.  The company posted adjusted earnings of $1.70 a share for the third quarter, above analysts’ consensus estimates of $1.62.  Zoetis  saw a particularly steep decline in revenue for its swine and poultry medicines.",
    "url": "https://finnhub.io/api/news?id=44eef593661e9e6d710442a34fa8b87e841a1bd84a960d0808b516f6bfbf7f59",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762264740,
      "headline": "This Animal Health Stock Tanks on Earnings. Pig and Chicken Medication Revenue Slumps.",
      "id": 137312648,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "Shares of  Zoetis  slumped Tuesday after the animal healthcare company reported weaker-than-expected quarterly revenue and slashed its full-year outlook.  The company posted adjusted earnings of $1.70 a share for the third quarter, above analysts’ consensus estimates of $1.62.  Zoetis  saw a particularly steep decline in revenue for its swine and poultry medicines.",
      "url": "https://finnhub.io/api/news?id=44eef593661e9e6d710442a34fa8b87e841a1bd84a960d0808b516f6bfbf7f59"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis (ZTS) Surpasses Q3 Earnings Estimates",
    "summary": "Zoetis (ZTS) delivered earnings and revenue surprises of +4.94% and -0.35%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=dcbbc6ed2c04bd2ea0d0783440cc719639b70e9a26ee5b1af160354f01f6a226",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762261803,
      "headline": "Zoetis (ZTS) Surpasses Q3 Earnings Estimates",
      "id": 137312649,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "Zoetis (ZTS) delivered earnings and revenue surprises of +4.94% and -0.35%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=dcbbc6ed2c04bd2ea0d0783440cc719639b70e9a26ee5b1af160354f01f6a226"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis (NYSE:ZTS) Reports Q3 In Line With Expectations But Stock Drops",
    "summary": "Animal health company Zoetis (NYSE:ZTS) met Wall Streets revenue expectations in Q3 CY2025, but sales were flat year on year at $2.4 billion. On the other hand, the company’s full-year revenue guidance of $9.44 billion at the midpoint came in 0.8% below analysts’ estimates. Its non-GAAP profit of $1.70 per share was 4.8% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=050264875430add7a27a7348e7890ed793ad39a35ab4a8f5772df368635722c3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762260136,
      "headline": "Zoetis (NYSE:ZTS) Reports Q3 In Line With Expectations But Stock Drops",
      "id": 137312650,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "Animal health company Zoetis (NYSE:ZTS) met Wall Streets revenue expectations in Q3 CY2025, but sales were flat year on year at $2.4 billion. On the other hand, the company’s full-year revenue guidance of $9.44 billion at the midpoint came in 0.8% below analysts’ estimates. Its non-GAAP profit of $1.70 per share was 4.8% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=050264875430add7a27a7348e7890ed793ad39a35ab4a8f5772df368635722c3"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis: No Longer A Growth Stock",
    "summary": "Zoetis shares have underperformed, falling over 25% in the past year, with recent guidance disappointing investors. Learn more about ZTS stock here.",
    "url": "https://finnhub.io/api/news?id=95c4b41f6aabf833ce19a9812817ef223038edace75d248b7713501d33c5044c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762260118,
      "headline": "Zoetis: No Longer A Growth Stock",
      "id": 137316143,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2205791995/image_2205791995.jpg?io=getty-c-w1536",
      "related": "ZTS",
      "source": "SeekingAlpha",
      "summary": "Zoetis shares have underperformed, falling over 25% in the past year, with recent guidance disappointing investors. Learn more about ZTS stock here.",
      "url": "https://finnhub.io/api/news?id=95c4b41f6aabf833ce19a9812817ef223038edace75d248b7713501d33c5044c"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis: Q3 Earnings Snapshot",
    "summary": "The Parsippany, New Jersey-based company said it had net income of $1.63 per share. Earnings, adjusted for non-recurring costs, were $1.70 per share. The results surpassed Wall Street expectations.",
    "url": "https://finnhub.io/api/news?id=95d430317cb7d720fbd3f27e025eacb4662334861e81448d867bf3729f567b3a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762257996,
      "headline": "Zoetis: Q3 Earnings Snapshot",
      "id": 137312651,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "The Parsippany, New Jersey-based company said it had net income of $1.63 per share. Earnings, adjusted for non-recurring costs, were $1.70 per share. The results surpassed Wall Street expectations.",
      "url": "https://finnhub.io/api/news?id=95d430317cb7d720fbd3f27e025eacb4662334861e81448d867bf3729f567b3a"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis Announces Third Quarter 2025 Results",
    "summary": "PARSIPPANY, N.J., November 04, 2025--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the third quarter of 2025.",
    "url": "https://finnhub.io/api/news?id=a3e84f2d66c44fbf270d909e19a7ce93e3fbc7231a53f836fac8faee39bcdcd1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762257600,
      "headline": "Zoetis Announces Third Quarter 2025 Results",
      "id": 137312652,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "PARSIPPANY, N.J., November 04, 2025--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the third quarter of 2025.",
      "url": "https://finnhub.io/api/news?id=a3e84f2d66c44fbf270d909e19a7ce93e3fbc7231a53f836fac8faee39bcdcd1"
    }
  },
  {
    "ts": null,
    "headline": "Veterinary Monoclonal Antibodies Market Research Global Forecast Report 2025: A $3.06 Billion Market by 2030, Driven by Upcoming Technologies, R&D Activities, and Product Launches",
    "summary": "The global veterinary monoclonal antibodies market is set to surge, reaching USD 3.06 billion by 2030, up from USD 1.70 billion in 2025, with a CAGR of 12.4%. This growth is driven by increasing pet ownership and heightened awareness of chronic diseases in pets. Despite challenges like rising pet care costs and strict regulations, expanding therapeutic uses offer new opportunities. Notably, the canine segment dominates due to the high incidence of skin conditions in dogs. By 2030, the subcutaneo",
    "url": "https://finnhub.io/api/news?id=83bf332603120f1dd090cacc75269928d258713930c64ee8240f641434aa7369",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762255560,
      "headline": "Veterinary Monoclonal Antibodies Market Research Global Forecast Report 2025: A $3.06 Billion Market by 2030, Driven by Upcoming Technologies, R&D Activities, and Product Launches",
      "id": 137312225,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "The global veterinary monoclonal antibodies market is set to surge, reaching USD 3.06 billion by 2030, up from USD 1.70 billion in 2025, with a CAGR of 12.4%. This growth is driven by increasing pet ownership and heightened awareness of chronic diseases in pets. Despite challenges like rising pet care costs and strict regulations, expanding therapeutic uses offer new opportunities. Notably, the canine segment dominates due to the high incidence of skin conditions in dogs. By 2030, the subcutaneo",
      "url": "https://finnhub.io/api/news?id=83bf332603120f1dd090cacc75269928d258713930c64ee8240f641434aa7369"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis Inc. 2025 Q3 - Results - Earnings Call Presentation",
    "summary": "2025-11-04. The following slide deck was published by Zoetis Inc.",
    "url": "https://finnhub.io/api/news?id=8ebb7dca87b0105abbdd971472dc7afba0c5dd4c67041c83aac5159c82283780",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762246889,
      "headline": "Zoetis Inc. 2025 Q3 - Results - Earnings Call Presentation",
      "id": 137311473,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "ZTS",
      "source": "SeekingAlpha",
      "summary": "2025-11-04. The following slide deck was published by Zoetis Inc.",
      "url": "https://finnhub.io/api/news?id=8ebb7dca87b0105abbdd971472dc7afba0c5dd4c67041c83aac5159c82283780"
    }
  }
]